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Carbon Disulfide
The September 1998 issue of EHP con-
tained two articles about the neurotoxicity
of carbon disulfide. The "NIEHS News"
article (1) reported on a collaborative study
that involved scientists from the NIEHS
(Research Triangle Park, NC), the U.S.
Environmental Protection Agency
(Research Triangle Park, NC), the
University ofNorth Carolina (Chapel Hill,
NC), Duke University (Durham, NC), and
Vanderbilt University (Nashville, TN). In
this study, the neurotoxicity of carbon
disulfide was detailed from the earliest mol-
ecular alterations to neurobehavioral find-
ings to electrophysiologic and morphologic
changes, and the utility of intramolecular
cross-linking in hemoglobin as a biomarker
was defined. I was pleased to read this
report, and even more pleased to have par-
ticipated in this study, but I was distressed
to see the cover story in the same issue.
"Multiple System Atrophy Following
Chronic Carbon Disulfide Exposure" (2),
in the "Grand Rounds in Environmental
Medicine," is a case report ofan individual
who developed a degenerative nervous sys-
tem disease, olivopontocerebellar atrophy,
and who had been chronically exposed to
carbon disulfide while working for 34 years
in a viscose rayon plant in the United
States. Frumkin (2) concluded, "While this
association has not previously been report-
ed, it is clinically and pathologically consis-
tent with a range of movement disorders
seen in the setting of occupational carbon
disulfide exposure."
Frumkin never saw this patient, nor
was he consulted by the patient's physi-
cians during the course of this disease; he
only reviewed the medical records and
diagnostic studies as an expert witness for
the plaintiff in a case that failed to con-
vince a Texas jury that a cause-and-effect
relationship existed between carbon disul-
fide exposure and this man's disease (3). I
also reviewed this material and concluded
that such a relationship was not even
remotely plausible; indeed, I thought that
there were excellent reasons to conclude
that his disease bore no relationship to the
exposure. Thus, the publication of this
paper raises several concerns: Why did
Frumkin feel authorized to publish this
report, and were the editors informed
about his relationship to this case? Was the
paper reviewed by experts in neurotoxicol-
ogy, clinical neurology, and neuropatholo-
gy? Will readers conclude that carbon
disulfide causes multisystem atrophy? How
many more lawsuits will be filed alleging
that since B followed A, A caused B, and
how many more physicians will reach this
vacuous conclusion?
The individual described in this paper
(2) had classical olivopontocerebellar
atrophy, beginning with cerebellar ataxia
and progressing over years to involve long
tracks and cranial nerve nuclei in the pons.
Neither the cerebellum nor the pontine
nuclei are affected in carbon disulfide toxic-
ity. However, Frumkin pointed out that
olivopontocerebellar atrophy is part of a
spectrum of diseases termed multisystem
atrophy, which also includes striatonigral
degeneration, a disease characterized by
clinical parkinsonism. Although extrapyra-
midal involvement in carbon disulfide toxi-
city has been alleged in the clinical literature
(4-11), the only experimental studies
reporting lesions in the extrapyramidal sys-
tem were published over 50 years ago and
involved uncontrolled exposures to carbon
disulfide that resulted in repeated apneic
episodes and confounding hypoxia (12-14).
Extrapyramindal lesions have never been
observed in modern experimental studies,
nor did the patient in Frumkin's report (2)
manifest extrapyramidal signs. On the other
hand, the most sensitive structure in the
nervous system to carbon disulfide-induced
damage is the axon, and this patient never
developed evidence for an axonopathy at
any time during his career or during his ter-
minal illness. Thus Frumkin's statement
that the patient's course ofillness was clini-
cally and pathologically consistent with car-
bon disulfide toxicity has no basis in fact.
Although it certainly was impressive to
see an MRI scan on the cover ofEHP, this
paper is not based in either strong science
or competent clinical medicine. We depend
upon physicians who practice occupational
and environmental medicine to apply the
science of toxicology to the evaluation and
treatment of patients who have been
exposed to toxicants. When the exposure
involves an agent whose toxicity has never
been suspected, case reports have value in
alerting physicians and the public to possi-
ble dangers. Considerable caution must be
exercised, however, in assigning cause-and-
effect relationships between toxicants and
disease, especially when the agent in ques-
tion has been in use for many decades, has
been studied extensively, and has been sub-
jected to strict regulatory standards.
Doyle G. Graham
Vanderbilt University Medical Center
Nashville, Tennessee
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Carbon Disulfide: Frumkin's
Response
Graham offers four discrete arguments
against an association between carbon
disulfide and olivopontocerebellar atrophy.
First, he holds that olivopontocerebellar
atrophy is clinically incompatible with car-
bon disulfide toxicity because carbon disul-
fide toxicity does not affect the cerebellum
or pontine nuclei. Second, he asserts that
the experimental studies showing extrapyra-
midal involvement in carbon disulfide toxi-
city relied on high-dose exposures at levels
sufficient to cause apnea. Third, he is con-
cerned that this experimental literature is
over 50 years old. Fourth, he argues that
the axon is more sensitive to carbon disul-
fide toxicity than are other parts ofthe ner-
vous system, suggesting that the absence of
axonopathy rules out carbon disulfide toxi-
city. Graham presents these arguments as
ex cathedra pronouncements and cites no
basis for any ofthem. In fact, each is con-
tradicted byavailable evidence.
With regard to cerebellar involvement
in carbon disulfide toxicity, Graham is fac-
tually incorrect. Autopsy studies in humans
with carbon disulfide toxicity are regrettably
rare, but at least two have shown clear evi-
dence of cerebellar involvement (1,2). The
animal toxicology is far more extensive and
has been reviewed in detail (3-5); numerous
reports show cerebellar involvement in
diverse species including rats (6), rabbits
(7), dogs (8), and cats (9). In fact, carbon
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disulfide can have quite widespread effects
in the central nervous system, leading the
World Health Organization (10) to con-
clude that
Psychic, pyramidal and extrapyramidal sympto-
matology, including signs from other parts ofthe
brain (vestibular, cerebellar) give a picture com-
patiblewith diffuse effects.
Graham's flat declaration that carbon disul-
fide spares the cerebellum contradicts
decades ofaccumulated evidence.
With regard to the doses used in experi-
mental studies of carbon disulfide toxicity,
Graham is again factually incorrect. He
first expressed his curious view in a previ-
ous publication (11), citing two studies for
support. One ofthese studies was a primate
study in which chronic exposure was punc-
tuated by accidental high-dose exposures
causing unconsciousness (but not apnea)
(12). In that study, all ofthe affected mon-
keys recovered promptly from their acute
intoxications and resumed a steady down-
hill course that continued for months. The
cerebellar damage later found in all four
monkeys on autopsy was therefore more
likely to have resulted from chronic expo-
sure than from acute anoxia. The second
study used dogs to test the effects ofchron-
ic carbon disulfide exposures (8). Although
Lewey et al. (8) did report an increase in
acute symptoms such as drowsiness and
gait abnormalities immediately after the
dogs were removed from test chambers,
they did not mention unconsciousness,
apnea, or other signs ofsevere acute toxicity
following any exposures. Severe changes in
the cortex and basal ganglia, and less severe
changes in the cerebellum, were observed in
the dogs on autopsy (13). In many other
animal studies showing cerebellar damage
from carbon disulfide including, for exam-
ple, the ones cited above (6,7,5, exposures
were chronic and at levels too low to cause
acute toxicity. Thus, Graham's belief that
cerebellar damage in animals resulted from
acute toxicity with anoxia is flatly contra-
dicted by the data, including the data he
cited to support his belief.
With regard to the age of the experi-
mental literature showing extrapyramidal
effects of carbon disulfide, Graham's rea-
soning is unsound. Unlike milk, knees, and
cars, scientific observations do not go bad
with time. Data of any vintage are over-
turned only if they are disproven by later
studies using the same methods, or if the
methods they used are later shown to be
invalid. Neither is true of the pathologic
studies discussed here.
With regard to the relative sensitivity
of axons to carbon disulfide toxicity,
Graham is partially correct. Peripheral
nerves are certainly a primary target ofcar-
bon disulfide [and Graham has made
important contributions to our under-
standing of this axonopathy (11,14)].
However, both human and animal obser-
vations demonstrate that central nervous
system manifestations may occur indepen-
dent of the peripheral manifestations, and
may even occur in the absence ofperipher-
al neuropathy. For example, in Lewey's
large series of 120 viscose rayon workers
(15), 76% ofsubjects had peripheral nerve
dysfunction and 21% had pyramidal and
extrapyramidal signs; the two findings
were statistically unassociated with each
other, suggesting that they occurred
through distinct mechanisms. In a more
recent series of21 grain handlers with car-
bon disulfide exposure, 18 had cogwheel
rigidity and/or akinesia, whereas only 13
had sensory loss and 7 had nerve conduc-
tion velocity and electromyelography
abnormalities (16). In one ofthe published
human autopsies, there were relatively
severe abnormalities in the cortex, cerebral
vasculature, basal ganglia, cerebellum, thal-
amus, pyramidal tracts, and anterior
columns, but only slight changes in the
peripheral nerves (2). Thus, Graham is
correct that peripheral nerve damage is
common in carbon disulfide toxicity, but
he seems to have gone further-insisting
that axonopathy is the only lesion, and the
sine qua non, of carbon disulfide toxicity.
The evidence clearlyshows otherwise.
Having said all this, I must admit that
it is difficult to muster too much passion in
defense of a case report. A case report is,
after all, only a case report. The most defin-
itive evidence of exposure-disease associa-
tions comes from well-designed epidemio-
logic studies supported by appropriate lab-
oratory data. Based on his earlier comments
(17), I suspect Graham and I would agree
that such evidence would add much to our
understanding.
Finally, with regard to medicolegal
issues, Graham is partially correct. After
reviewing the case, forming an impression,
and writing the case report, I did testify in
the trial brought by the patient and his sur-
vivors (18). The jury's conclusions have lit-
tle relevance to Graham's scientific concerns
or my response, but because he raised the
issue, I would like to provide clarification.
The jury indeed found for the defendant,
not because the jury members rejected a
link between carbon disulfide and disease,
but because theyaccepted the "sophisticated
employer defense." The jury held that the
defendant, an outside firm that produced
and supplied carbon disulfide to the
patient's employer, could not be held liable
for exposures that occurred on the employ-
er's premises, when the employer should
have known enough to handle the carbon
disulfide safely.
Howard Frumkin
Rollins School ofPublic Health
ofEmory University
Atlanta, Georgia
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Editor's note: Theprecedingletters ofGraham
and Frumkin are an inevitable but not
unwelcome developmentfor "Grand Rounds
in Environmental Medicine." These letters
rejlectthe nuancessurroundingissuesofcausa-
tion that often accompany real cases in this
area. They also highlight the tension that can
develop among experts when these cases enter
the arena oflitigation. This is not an uncom-
mon occurrence in clinical environmental
medicine. Although providing opinions and
otherwise being involved in litigation may
Environmental Health Perspectives . Volume 108, Number 3, March 2000 A 1 1 1Correspondence
provoke distaste in some medicalpractitioners,
it nevertheless comprises an important duty;
interestedparties andcourts needexpert, well-
informed opinions as a basisfor settling dis-
putes. In thesecondyear of"GrandRounds in
Environmental Medicine," we once again
express our interest in receiving submissions
that are educational, well written, and capa-
bleofwithstandingrigorouspeerreview.
HowardHu
MedicalEditor
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Excellence
in basic research at the
National Institute of Environmental Health Sciences
, . ; !js:@.g.. J_.. ,,,,,http:llwww..niehs.nih.I h gov/
NIEHSscientists and grantees are performing basic studies of our susceptibility to environment- A part ofthe Nationa'l
related disease: demonstrating that a carcinogen in cigarette smoke (benzo(a)pyrene) alters part of a Institutes of Health,
gene to cause lung cancer ... showing the effects of fetal exposure to PCBs ... developing a strain of
mouse that lacks functional estrogen receptors and that helps evaluate how some pesticides and other the National Institute
estrogen-like compounds might affect development and reproduction . .. discovering the genes for ofEnvironmental Health
breast, ovarian, and prostate cacers... identifying women's optimal days offertlky... seeking to reverse
the damage from lead exposure .. finding alternatives to traditional animal tests ... pinpointing the Sciences is located in
functions ofspecific genes by eliminating them from specially bred mouse lines... discovering a way, using Research Triangle Park,
ordinary yeast cells, to isolate and clone genes and other fragments ofgenetic material more quickly ...
showing the effects of urban air on lung function ... North Carolina.
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